YC
Yi Chen HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
127
Avg Return
Past Year
Past Year
8.9%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
94.3%
Neutral
5.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Financials
Asset Management
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Health Information Services
Medical Devices
Medical Distribution
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $5 |
16%
downside
| 2 | +82% |
0
%
| 3 Nov ‘25 7 months ago |
|
|
|
Buy
Maintained
| $2.50 |
15%
upside
| 4 | -8.9% |
0
%
| 7 Oct ‘25 8 months ago |
|
|
|
Neutral
Downgraded
| – | – | 4 | +113% |
0
%
| 29 Sep ‘25 8 months ago |
|
|
|
Buy
Reiterated
| $7 |
361%
upside
| 2 | +20% |
0
%
| 23 Sep ‘25 8 months ago |
|
|
|
Buy
Reiterated
| $7 |
182%
upside
| 2 | -5.8% |
0
%
| 11 Sep ‘25 9 months ago |
|
|
|
Neutral
Downgraded
| $48 |
0%
upside
| 2 | +192% |
0
%
| 10 Sep ‘25 9 months ago |
|
|
|
Buy
Maintained
| $10 |
152%
upside
| 2 | +27% |
0
%
| 4 Sep ‘25 9 months ago |
|
|
|
Buy
Reiterated
| $10 |
307%
upside
| 2 | -17% |
0
%
| 2 Sep ‘25 9 months ago |
|
|
|
Buy
Reiterated
| $4 |
254%
upside
| 5 | +2.5% |
0
%
| 2 Sep ‘25 9 months ago |
|
|
|
Buy
Reiterated
| $9 |
162%
upside
| 2 | -1.6% |
0
%
| 2 Sep ‘25 9 months ago |
|
|
|
Buy
Maintained
| $8 |
195%
upside
| 2 | -6.1% |
0
%
| 12 Aug ‘25 10 months ago |
|
|
|
Neutral
Downgraded
| – | – | 3 | +0.9% |
0
%
| 1 Aug ‘25 10 months ago |
|
|
|
Neutral
Downgraded
| $75 |
18,193%
upside
| 3 | -20% |
0
%
| 18 Jul ‘25 11 months ago |
|
|
|
Buy
Reiterated
| $16 |
34%
upside
| 2 | +10% |
0
%
| 16 Jul ‘25 11 months ago |
|